These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1640727)

  • 21. Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes.
    Nagler A; MacKichan ML; Negrin RS; Donlon T; Greenberg PL
    Leukemia; 1995 Jan; 9(1):30-9. PubMed ID: 7531261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.
    Greenberg P; Negrin R; Nagler A; Vincent M; Donlon T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():293-300; discussion 300-2. PubMed ID: 1691248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
    Ganser A; Hoelzer D
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematopoietic growth factors in primary and therapy-related bone marrow insufficiency].
    Hansen B; Hippe E; Jacobsen GK; Johnsen HE
    Ugeskr Laeger; 1992 Jun; 154(24):1697-702. PubMed ID: 1378668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
    Ganser A; Seipelt G; Verbeek W; Ottmann OG; Maurer A; Kolbe K; Hess U; Elsner S; Reutzel R; Wörmann B
    Leukemia; 1994 Mar; 8(3):369-75. PubMed ID: 7510354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.
    Piacibello W; Sanavio F; Bresso P; Severino A; Carlesso N; Pregno P; Stacchini A; Morelli S; Fubini L; Gallo E
    Leukemia; 1994 Feb; 8(2):250-7. PubMed ID: 7508532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Benninger L; Patel SR; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome.
    Bessho M; Itoh Y; Kataumi S; Kawai N; Matsuda A; Jinnai I; Saitoh M; Hirashima K; Minamihisamatsu M
    Leuk Res; 1992; 16(2):123-31. PubMed ID: 1545564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
    Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
    Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia.
    Antin JH; Weinberg DS; Rosenthal DS
    Exp Hematol; 1990 May; 18(4):266-70. PubMed ID: 2182331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
    Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
    Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro cytogenetic effects of recombinant human hematopoietic growth factors on cells derived from myelodysplastic syndromes.
    Ohyashiki K; Fujieda H; Iwabuchi A; Ohyashiki JH; Toyama K
    Cancer Genet Cytogenet; 1990 Sep; 48(2):169-78. PubMed ID: 1697782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.
    Ganser A; Janssen JW; Ottmann OG; Seipelt G; Eder M; Becher R; Lindermann A; Herrmann F; Schulz G; Mertelsmann R
    Leukemia; 1991 Jun; 5(6):487-92. PubMed ID: 1676079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.
    Herrmann F; Mertelsmann R; Lindemann A; Ottmann OG; Seipelt G; Oster W; Hoelzer D; Ganser A
    Biotechnol Ther; 1991; 2(3-4):299-311. PubMed ID: 1845132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
    Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
    Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
    Wright DG; LaRussa VF; Salvado AJ; Knight RD
    J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.